New scan
You checked
Glimepiride / Gliclazide
SACAA Part 67 assessment
Not acceptable / incompatible with flying duties
Active ingredient(s)
Glimepiride / Gliclazide
Sulphonylurea antidiabetic
Guidance notes
Not listed in SA-CATS 67 Table A1 and therefore requires SACAA verification before use. Significant in-flight hypoglycaemia risk — treat as unacceptable pending individual SACAA consideration.
Known SA brand names
AmarylDiamicron
Contact a professional
Our partner Buchner Med can assist with aviation medical assessments and DAME consultations. Alternatively, find an SACAA-certified DAME directly through the official list.
Possible acceptable alternatives (same therapeutic group)
Alternatives are informational only. The underlying medical condition must also be assessed by a DAME — a condition can ground you even when the medicine is acceptable.